On electrostatic interactions of adenosine triphosphate–insulin‐degrading enzyme revealed by quantum mechanics/molecular mechanics and molecular dynamics
Abstract
Abstract The insulin‐degrading enzyme (IDE) plays a significant role in the degradation of the amyloid beta (Aβ), a peptide found in the brain regions of the patients with early Alzheimer’s disease. Adenosine triphosphate (ATP) allosterically regulates the Aβ‐degrading activity of IDE. The present study investigates the electrostatic interactions between ATP‐IDE at the allosteric site of IDE, including thermostabilities/flexibilities of IDE residues, which have not yet been explored systematically. This study applies the quantum mechanics/molecular mechanics (QM/MM) to the proposed computational model for exploring electrostatic interactions between ATP and IDE. Molecular dynamic (MD) simulations are performed at different temperatures for identifying flexible and thermostable residues of IDE. The proposed computational model predicts QM/MM energy‐minimised structures providing the IDE residues (Lys530 and Asp385) with high binding affinities. Considering root mean square fluctuation values during the MD simulations at 300.00 K including heat‐shock temperatures (321.15 K and 315.15 K) indicates that Lys530 and Asp385 are also the thermostable residues of IDE, whereas Ser576 and Lys858 have high flexibilities with compromised thermostabilities. The present study sheds light on the phenomenon of biological recognition and interactions at the ATP‐binding domain, which may have important implications for pharmacological drug design. The proposed computational model may…
Read the paper
Related studies
- Chaos and quantum thermalization
- The Dalton quantum chemistry program system
- Cord Blood Leptin and Adiponectin as Predictors of Adiposity in Children at 3 Years of Age: A Prospective Cohort Study
- Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes
- Stable adiabatic quantum batteries
- A novel self-lipid antigen targets human T cells against CD1c(+) leukemias
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.